SRTS insider buying
6 cluster buysSensus Healthcare, Inc.
When two or more insiders at Sensus Healthcare, Inc. buy SRTS on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in SRTS plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Aug 20 – Aug 31, 2026Detected Aug 31, 2026High conviction2 insidersTotal bought$563.5KMarket capUnknown
- Aug 20 – Aug 27, 2026Detected Aug 28, 2026High conviction2 insidersTotal bought$337.9KMarket capUnknown
- Aug 20 – Aug 24, 2026Detected Aug 25, 2026High conviction2 insidersTotal bought$271.2KMarket capUnknown
3 more clusters in SRTS
Sign in free to see the full history, or go Pro for real-time alerts the moment new insider clusters form.
All notable open-market buys in SRTS
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 31, 2026 | Sachetta Ericcluster Director | 27,304 | $3.54 | $96.6K | SEC ↗ |
| Aug 28, 2026 | Sachetta Ericcluster Director | 37,537 | $3.44 | $129.0K | SEC ↗ |
| Aug 27, 2026 | Sachetta Ericcluster Director | 10,925 | $3.18 | $34.8K | SEC ↗ |
| Aug 26, 2026 | Sachetta Ericcluster Director | 9,708 | $3.29 | $31.9K | SEC ↗ |
| Aug 24, 2026 | Sachetta Ericcluster Director | 34,697 | $3.25 | $112.9K | SEC ↗ |
| Aug 21, 2026 | Sachetta Ericcluster Director | 7,000 | $3.25 | $22.8K | SEC ↗ |
| Aug 20, 2026 | Sachetta Ericcluster Director | 24,000 | $3.13 | $75.1K | SEC ↗ |
| Aug 20, 2026 | Sardano Joseph Ccluster Director, CHIEF EXECUTIVE OFFICER | 20,000 | $3.02 | $60.5K | SEC ↗ |
| Feb 24, 2026 | Director | 2,000 | $3.81 | $7.6K | SEC ↗ |
| Nov 21, 2025 | Sachetta Ericcluster Director | 7,000 | $3.93 | $27.5K | SEC ↗ |
| Nov 18, 2025 | Sardano Joseph Ccluster Director, CHIEF EXECUTIVE OFFICER | 25,000 | $4.03 | $100.8K | SEC ↗ |
| Nov 18, 2025 | Sardano Michaelcluster Director, PRESIDENT AND GENERAL COUNSEL | 1,000 | $3.80 | $3.8K | SEC ↗ |
| Nov 13, 2025 | Sachetta Ericcluster Director | 2,500 | $4.50 | $11.3K | SEC ↗ |
| Nov 11, 2025 | Sardano Michaelcluster Director, PRESIDENT AND GENERAL COUNSEL | 1,000 | $4.26 | $4.3K | SEC ↗ |
| Aug 13, 2025 | Director, PRESIDENT AND GENERAL COUNSEL | 1,000 | $3.37 | $3.4K | SEC ↗ |
| Feb 10, 2025 | Sardano Michaelcluster Director, PRESIDENT AND GENERAL COUNSEL | 1,000 | $5.95 | $6.0K | SEC ↗ |
| Feb 10, 2025 | Rampolla Javiercluster CHIEF FINANCIAL OFFICER | 501 | $5.95 | $3.0K | SEC ↗ |
SRTS insider buying — FAQ
- Are insiders buying SRTS stock?
- Yes — 5 distinct insiders have bought SRTS (Sensus Healthcare, Inc.) on the open market, including 6 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Aug 31, 2026.
- How much SRTS stock have insiders bought?
- Insiders have bought a combined $731.0K of SRTS across 17 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in SRTS?
- A cluster buy is two or more distinct Sensus Healthcare, Inc. insiders — officers, directors, or 10% owners — each buying SRTS on the open market within a rolling window. SRTS has 6 detected cluster buys to date.
- Where does this SRTS insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in SRTS
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy SRTS within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding SRTS.